Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Hepatitis

Free Subscription Articles published in Hepatology Retrieve available abstracts of 334 articles: HTML format Text format

Single Articles

March 2010
1. PAWLOTSKY JM , Chevaliez S
   Preventing hepatitis C virus recurrence in liver transplant recipients: A role for adoptive immunotherapy?
   Hepatology. 2010;51:1072-1076.
   PubMed     Text format     Related articles   
   
   
   February 2010
2. MITCHELL AE , Colvin HM, Palmer Beasley R
   Institute of Medicine recommendations for the prevention and control of hepatitis B and C.
   Hepatology. 2010;51:729-733.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. SANYAL AJ
   The Institute of Medicine report on viral hepatitis: A call to action.
   Hepatology. 2010;51:727-728.
   PubMed     Text format     Related articles   
   
   
   
4. WONG VW , Wong GL, Yan KK, Chim AM, et al
   Durability of peginterferon alfa-2b treatment at 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.
   Hepatology. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
5. WANG CC , Kao JH
   Metformin improves sustained virologic response in difficult-to-cure hepatitis C: More questions than answers.
   Hepatology. 2010;51:1082.
   PubMed     Text format     Related articles   
   
   
   
6. JAN CF , Huang KC, Chien YC, Greydanus DE, et al
   Determination of immune memory to hepatitis B vaccination through early booster response in college students.
   Hepatology. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. BRUNO S , Crosignani A, Facciotto C, Rossi S, et al
   Sustained virologic response prevents the development of esophageal varices in compensated, child-pugh class a hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study.
   Hepatology. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. DIAGO M , Shiffman ML, Bronowicki JP, Zeuzem S, et al
   Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirin.
   Hepatology. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. TERRAULT N , Khalili M
   A glimpse of future hepatitis C virus treatment paradigms.
   Hepatology. 2010;51:707-710.
   PubMed     Text format     Related articles   
   
   
   
10. SHACKEL NA , Bowen DG, McCaughan GW
    Snipping away at hepatitis C.
    Hepatology. 2010;51:703-705.
    PubMed     Text format     Related articles   
    
    
    
11. CHANG TT , Lai CL, Kew Yoon S, Lee SS, et al
    Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
12. COHEN D , Adamovich Y, Reuven N, Shaul Y, et al
    Hepatitis B virus activates deoxynucleotide synthesis in nondividing hepatocytes by targeting the R2 gene.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. KUNIHOLM MH , Kovacs A, Gao X, Xue X, et al
    Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. AIT-GOUGHOULTE M , Banerjee A, Meyer K, Mazumdar B, et al
    Hepatitis C virus core protein interacts with fibrinogen-beta and attenuates cytokine stimulated acute-phase response.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. LOK AS
    Should antiviral treatment be extended to patients with chronic hepatitis B and mildly elevated alanine aminotransferase?
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
16. PETTA S , Camma C, Scazzone C, Tripodo C, et al
    Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
17. KOCHAR R , Fallon M
    Diagnostic criteria for autoimmune hepatitis: What is the gold standard?
    Hepatology. 2009;51:350-351.
    PubMed     Text format     Related articles   
    
    
    
18. MARTINOT-PEIGNOUX M , Stern C, Maylin S, Ripault MP, et al
    Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. KRIEGER SE , Zeisel MB, Davis C, Thumann C, et al
    Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-Claudin-1 associations.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. YUEN MF , Han KH, Um SH, Yoon SK, et al
    Antiviral activity and safety of LB80380 in hepatitis B e antigen-positive chronic hepatitis B patients with lamivudine-resistant disease.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. SIMONETTI J , Bulkow L, McMahon BJ, Homan C, et al
    Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. KNAPP S , Warshow U, Hegazy D, Brackenbury L, et al
    Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. BINI EJ , Perumalswami PV
    Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: Prevalence, racial/ethnic differences, and viral interactions.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. FULLER MJ , Shoukry NH, Gushima T, Bowen DG, et al
    Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. KROY DC , Beraza N, Tschaharganeh DF, Sander LE, et al
    Lack of interleukin-6/glycoprotein 130/signal transducers and activators of transcription-3 signaling in hepatocytes predisposes to liver steatosis and injury in mice.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. FEUERSTADT P , Bunim AL, Garcia H, Karlitz JJ, et al
    Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. BELLECAVE P , Sarasin-Filipowicz M, Donze O, Kennel A, et al
    Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. LEE HW , Lee HJ, Hwang JS, Sohn JH, et al
    Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. MORIGUCHI H , Chung RT, Sato C
    An identification of the novel combination therapy for hepatitis C virus 1b infection by using a replicon system and human induced pluripotent stem cells.
    Hepatology. 2009;51:351-352.
    PubMed     Text format     Related articles   
    
    
    
30. WU IC , Lai CL, Han SH, Han KH, et al
    Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. CHEVALIEZ S , Fix J, Soulier A, Pawlotsky JM, et al
    Underestimation of hepatitis C virus genotype 4 RNA levels by the Cobas AmpliPrep/Cobas TaqMan assay.
    Hepatology. 2009;50:1681.
    PubMed     Text format     Related articles   
    
    
    
32. GERMER JJ , Bommersbach CE, Schmidt DM, Bendel JL, et al
    Quantification of genotype 4 hepatitis C virus RNA by the COBAS AmpliPrep/COBAS TaqMan hepatitis C virus test.
    Hepatology. 2009;50:1679-80.
    PubMed     Text format     Related articles   
    
    
    
33. PURNAK T , Ozaslan E
    Coffee intake and chronic hepatitis C.
    Hepatology. 2009;50:1673.
    PubMed     Text format     Related articles   
    
    
    October 2009
34. TUAILLON E , Mondain AM, Meroueh F, Ottomani L, et al
    Dried blood spot for hepatitis C virus serology and molecular testing.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. HOU W , Tian Q, Zheng J, Bonkovsky HL, et al
    MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. WANG CC , Kao JH
    Hepatitis C virus infection, lipids, and coronary heart disease: A Pandora's box.
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
37. NUNEZ M
    Routine hepatitis B virus DNA testing in human immunodeficiency virus-infected patients with positive hepatitis B core antibody but negative hepatitis B surface antigen is not justified by current evidence.
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
38. DUONG FH , Christen V, Lin S, Heim MH, et al
    Hepatitis C virus-induced up-regulation of protein phosphatase 2A inhibits histone modification and DNA damage repair.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. MORIGUCHI H , Chung RT, Sato C
    New translational research on novel drugs for hepatitis C virus 1b infection by using a replicon system and human induced pluripotent stem cells.
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
40. ZHANG L , Wang G, Hou W, Li P, et al
    Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: An analytical review.
    Hepatology. 2009;51:690-698.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. CARRION JA , Torres F, Crespo G, Miquel R, et al
    Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. PARK SJ , Lim YS, Hwang S, Heo NY, et al
    Emergency adult-to-adult living-donor liver transplantation for acute liver failure in a hepatitis B virus endemic area.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. GEROLDI D , Emanuele E
    Metformin in chronic hepatitis C virus hepatitis: Caution needed with sex-based subgroup analysis.
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
44. DURANTEL D , Zoulim F
    Innate response to hepatitis B virus infection: Observations challenging the concept of a stealth virus.
    Hepatology. 2009;50:1692-1695.
    PubMed     Text format     Related articles   
    
    
    
45. YILMAZ Y , Yonal O, Imeryuz N
    Metformin, hepatitis C, and insulin resistance: Sufficient evidence?
    Hepatology. 2009;50:2054-2055.
    PubMed     Text format     Related articles   
    
    
    September 2009
46. LEISE M , Kim WR
    Hepatitis C nonresponders: Re-treat or retreat?
    Hepatology. 2009;50:1307-1309.
    PubMed     Text format     Related articles   
    
    
    
47. REIN DB , Lesesne SB, O'Fallon A, Weinbaum CM, et al
    Prevalence of hepatitis B surface antigen among refugees entering the United States between 2006 and 2008.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. BRUNO S , Shiffman ML, Roberts SK, Gane EJ, et al
    Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. CHEN YC , Chu CM, Liaw YF
    Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. LANGE CM , Bojunga J, Hofmann WP, Wunder K, et al
    Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function.
    Hepatology. 2009;50:2001-2006.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. LEHMANN E , El-Tantawy WH, Ocker M, Bartenschlager R, et al
    The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. EVERHART JE , Wright EC, Goodman ZD, Dienstag JL, et al
    Prognostic value of Ishak fibrosis stage: Findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.
    Hepatology. 2009;51:585-594.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. CIESEK S , Steinmann E, Wedemeyer H, Manns MP, et al
    Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. ZHANG JY , Zhang Z, Lin F, Zou ZS, et al
    Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. HUTTON DW , So SK, Brandeau ML
    Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. FAN X , Mao Q, Zhou D, Lu Y, et al
    High diversity of hepatitis C viral quasispecies is associated with early virological response in patients undergoing antiviral therapy.
    Hepatology. 2009;50:1765-1772.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. BENGA WJ , Krieger SE, Dimitrova M, Zeisel MB, et al
    Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. NEUMANN-HAEFELIN C , Timm J, Schmidt J, Kersting N, et al
    Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope.
    Hepatology. 2009;51:54-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. LO GH
    Re-treating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: really safe and effective?
    Hepatology. 2009;50:988.
    PubMed     Text format     Related articles   
    
    
    
60. LOK AS , McMahon BJ
    Chronic hepatitis B: update 2009.
    Hepatology. 2009;50:661-2.
    PubMed     Text format     Related articles   
    
    
    
61. MARRA F , Bertolani C
    Adipokines in liver diseases.
    Hepatology. 2009;50:957-69.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
62. CHANG S , Kodys K, Szabo G
    Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. VAN BOMMEL F , de Man RA, Wedemeyer H, Deterding K, et al
    Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. ZHAO J , Wu G, Bu F, Lu B, et al
    Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region- containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma.
    Hepatology. 2009;51:142-153.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. MILNER KL , Chisholm D, George J
    The many faces of hepatitis c: Liver disease and type 2 diabetes.
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
66. COREY KE , Kane E, Munroe C, Barlow LL, et al
    Hepatitis C virus infection and its clearance alter circulating lipids: Implications for long-term follow-up.
    Hepatology. 2009;50:1030-1037.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. PRADAT P , Trepo E, Potthoff A, Bakshi R, et al
    The cirrhosis risk score predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
68. VOLK ML , Tocco R, Saini S, Lok AS, et al
    Public health impact of antiviral therapy for hepatitis C in the United States.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. GONZALEZ O , Fontanes V, Raychaudhuri S, Loo R, et al
    The heat shock protein inhibitor Quercetin Attenuates hepatitis C virus production.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. LUCIFORA J , Durantel D, Testoni B, Hantz O, et al
    Control of hepatitis B virus replication by innate response of HepaRG cells.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. HOSEL M , Quasdorff M, Wiegmann K, Webb D, et al
    Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection.
    Hepatology. 2009;50:1773-1782.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. NELSON DR
    Hepatitis C drug development at a crossroads.
    Hepatology. 2009;50:997-999.
    PubMed     Text format     Related articles   
    
    
    
73. GOODMAN ZD , Stoddard AM, Bonkovsky HL, Fontana RJ, et al
    Fibrosis progression in chronic hepatitis C: Morphometric image analysis in the HALT-C trial.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. ITSUI Y , Sakamoto N, Kakinuma S, Nakagawa M, et al
    Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. ROMERO-GOMEZ M , Diago M, Andrade RJ, Calleja JL, et al
    Treatment of insulin resistance with metformin in naive genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. RUSTGI VK , Lee WM, Lawitz E, Gordon SC, et al
    Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. SUSSER S , Welsch C, Wang Y, Zettler M, et al
    Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. KRUSE N , Neumann K, Schrage A, Derkow K, et al
    Priming of CD4(+) T cells by liver sinusoidal endothelial cells induces CD25(low) forkhead box protein 3(-) regulatory T cells suppressing autoimmune hepatitis.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
79. HOWELL JA , Visvanathan K
    A novel role for human leukocyte antigen-DP in chronic hepatitis B infection: A genomewide association study.
    Hepatology. 2009;50:647-649.
    PubMed     Text format     Related articles   
    
    
    
80. SIMONIN Y , Disson O, Lerat H, Antoine E, et al
    Calpain activation by hepatitis C virus proteins inhibits the extrinsic apoptotic signaling pathway.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. RASHID M , Mitchell JD, Cramp ME, Cross TJ, et al
    Limitations of the algorithm for the SAFE biopsy: A noninvasive fibrosis measure in chronic hepatitis C.
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
82. WIEGAND J , Patel K, Tillmann HL
    Does hepatitis B surface antigen kinetics, including both decline and reaching a threshold, improve prediction of response?
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
83. FREEDMAN ND , Everhart JE, Lindsay KL, Ghany MG, et al
    Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. WANG SH , Yeh SH, Lin WH, Wang HY, et al
    Identification of androgen response elements in the enhancer I of hepatitis B virus: A mechanism for sex disparity in chronic hepatitis B.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. ZHANG M , Han Y, Han C, Xu S, et al
    The beta2 integrin CD11b attenuates polyinosinic:Polycytidylic acid-induced hepatitis by negatively regulating natural killer cell functions.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. NASCIMBENI M , Montange T, Law HK, Mallet V, et al
    Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells.
    Hepatology. 2009;51:353.
    PubMed     Text format     Related articles   
    
    
    
87. CHEN EQ , Tang H
    Hepatitis B e antigen as a predictor for hepatitis B e antigen-positive chronic hepatitis B patients with peginterferon alfa-2a therapy.
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
88. BUTT AA , Wang X, Moore CG
    Effect of hepatitis C virus and its treatment on survival.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. TSUTSUMI T , Matsuda M, Aizaki H, Moriya K, et al
    Proteomics analysis of mitochondrial proteins reveals overexpression of a mitochondrial protein chaperon, prohibitin, in cells expressing hepatitis C virus core protein.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. ZHANG R , Wang L, Yu GR, Zhang X, et al
    MicroRNA-122 might be a double-edged sword in hepatocellular carcinoma.
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
91. DEUFFIC-BURBAN S , Babany G, Lonjon-Domanec I, Deltenre P, et al
    Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. FIEL MI , Schiano T
    Acute cellular rejection and its sequelae developing in a 42-year-old man after liver transplantation.
    Hepatology. 2009;50:650-651.
    PubMed     Text format     Related articles   
    
    
    
93. DENG Q , Mancini-Bourgine M, Zhang X, Cumont MC, et al
    Hepatitis B virus as a gene delivery vector activating foreign antigenic T cell response that abrogates viral expression in mouse models.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. BERENGUER J , Alvarez-Pellicer J, Martin PM, Lopez-Aldeguer J, et al
    Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. SHIM JH , Suh DJ, Kim KM, Lim YS, et al
    Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
96. BOONSTRA A , van der Laan LJ, Vanwolleghem T, Janssen HL, et al
    Experimental models for hepatitis C viral infection.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. LO GH
    The management of cirrhotic ascites.
    Hepatology. 2009;50:1320.
    PubMed     Text format     Related articles   
    
    
    
98. MACIAS J , Berenguer J, Japon MA, Giron JA, et al
    Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. ROBERTS SK , Weltman MD, Crawford DH, McCaughan GW, et al
    Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: A randomized controlled trial.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. ZHANG R , Wang L, Yang AG
     Is microRNA-143 really a turncoat of tumor suppressor microRNA in hepatitis B virus-related hepatocellular carcinoma?
     Hepatology. 2009.
     PubMed     Text format     Related articles   
     
     
     
101. ASRANI SK , Kim WR, Heimbach JK
     Survival benefit of liver transplantation: One size fits all or fits none?
     Hepatology. 2009;50:352-354.
     PubMed     Text format     Related articles   
     
     
     
102. ZHAO H , Miao R
     A call for attention and trials on hepatitis B e antigen-negative, alanine aminotransferase-normal chronic hepatitis B virus infection.
     Hepatology. 2009.
     PubMed     Text format     Related articles   
     
     
     
103. HALFON P , Martinot-Peignoux M, Cacoub P
     The myth of occult hepatitis C infection.
     Hepatology. 2009.
     PubMed     Text format     Related articles   
     
     
     
104. MARCOLONGO M , Young B, Dal Pero F, Fattovich G, et al
     A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. DALGARD O , Mangia A
     Management of patients with hepatitis C virus genotype 2 or 3: Comments on updated american association for the study of liver diseases practice guidelines.
     Hepatology. 2009;50:323.
     PubMed     Text format     Related articles   
     
     
     
106. MILNER KL , van der Poorten D, Xu A, Bugianesi E, et al
     Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease.
     Hepatology. 2009;49:1926-34.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. LUCENA MI , Andrade RJ, Kaplowitz N, Garcia-Cortes M, et al
     Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex.
     Hepatology. 2009;49:2001-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. INATSU A , Kinoshita M, Nakashima H, Shimizu J, et al
     Novel mechanism of C-reactive protein for enhancing mouse liver innate immunity.
     Hepatology. 2009;49:2044-54.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2009
109. KENNY-WALSH E
     Increased liver-related mortality to hepatitis C viremia defined on the 20th anniversary of its identification.
     Hepatology. 2009;50:349-351.
     PubMed     Text format     Related articles   
     
     
     
110. GIUGLIANO S , Oezkan F, Bedrejowski M, Kudla M, et al
     Degree of cross-genotype reactivity of hepatitis C virus-specific CD8+ T cells directed against NS3.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. RAUCH A , James I, Pfafferott K, Nolan D, et al
     Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. DAI CY , Chuang WL, Huang JF, Hsieh MY, et al
     Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in patients with chronic hepatitis C, using viral and host factors: Some concerns.
     Hepatology. 2009;49:2125.
     PubMed     Text format     Related articles   
     
     
     
113. PUOTI L , Bellis L, Guarisco R
     Liver biopsy in hepatitis C virus carriers with normal alanine aminotransferase levels.
     Hepatology. 2009.
     PubMed     Text format     Related articles   
     
     
     
114. EMANUELE E
     Statins and hepatitis C virus: Friend or foe?
     Hepatology. 2009.
     PubMed     Text format     Related articles   
     
     
     
115. SWAN T , Curry J
     Comment on the updated AASLD practice guidelines for the diagnosis, management, and treatment of hepatitis C: Treating active drug users.
     Hepatology. 2009;50:323-324.
     PubMed     Text format     Related articles   
     
     
     
116. BENHAMOU Y , Afdhal NH, Nelson DR, Shiffman ML, et al
     A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naive patients with chronic hepatitis C: ViSER1 results.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. KIM H , Oh BK, Roncalli M, Park C, et al
     Large liver cell change in hepatitis B virus-related liver cirrhosis.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. HSU C , Wei SC, Cheng AL, Chen PJ, et al
     Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy.
     Hepatology. 2009;50:654-655.
     PubMed     Text format     Related articles   
     
     
     
119. STUDACH LL , Rakotomalala L, Wang WH, Hullinger RL, et al
     Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
120. LEI RX , Shi H, Peng XM, Zhu YH, et al
     Influence of a single nucleotide polymorphism in the P1 promoter of the furin gene on transcription activity and hepatitis B virus infection.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. KOTTILIL S , Yan MY, Reitano KN, Zhang X, et al
     Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells.
     Hepatology. 2009;50:34-45.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. LAURENCE A , Klennerman P
     Interleukin 27 and viral hepatitis: Smarter than the average cytokine.
     Hepatology. 2009.
     PubMed     Text format     Related articles   
     
     
     
123. TOY M , Veldhuijzen IK, de Man RA, Richardus JH, et al
     Potential impact of long-term nucleoside therapy on the mortality and morbidity of active chronic hepatitis B.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. DOO EC , Hoofnagle JH, Rodgers GP
     NIH consensus development conference: management of Hepatitis B. Introduction.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles   
     
     
     
125. HASSAN MM , Kaseb A, Li D, Patt YZ, et al
     Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States.
     Hepatology. 2009;49:1563-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. BASSO M , Giannini EG, Torre F, Blanchi S, et al
     Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse.
     Hepatology. 2009;49:1442-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. PARK O , Jeong WI, Wang L, Wang H, et al
     Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride.
     Hepatology. 2009;49:1683-94.
     PubMed     Text format     Related articles    Abstract available
     
     
     April 2009
128. MURATORI P , Granito A, Pappas G, Muratori L, et al
     Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients.
     Hepatology. 2009;49:1782-1783.
     PubMed     Text format     Related articles   
     
     
     
129. EYRE NS , Baumert TF, Beard MR
     Closing the gap: The tight junction protein occludin and hepatitis C virus entry.
     Hepatology. 2009;49:1770-1772.
     PubMed     Text format     Related articles   
     
     
     
130. NATTERMANN J , Tacke F
     The structure behind diversity: Covariance networks in hepatitis C virus sequences are associated with treatment response.
     Hepatology. 2009;49:1767-1769.
     PubMed     Text format     Related articles   
     
     
     
131. ROTMAN Y , Brown TA, Hoofnagle JH
     Evaluation of the patient with hepatitis B.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. THIO CL
     Hepatitis B and human immunodeficiency virus coinfection.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. WEINBAUM CM , Mast EE, Ward JW
     Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
134. LIANG TJ
     Hepatitis B: The virus and disease.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. PETERS MG
     Special populations with hepatitis B virus infection.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. DI BISCEGLIE AM
     Hepatitis B and hepatocellular carcinoma.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
137. PERRILLO R
     Benefits and risks of interferon therapy for hepatitis B.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. DOO EC , Hoofnagle JH
     The hepatitis B research network.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles   
     
     
     
139. SORRELL MF , Belongia EA, Costa J, Gareen IF, et al
     National Institutes of Health consensus development conference statement: Management of hepatitis B.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles   
     
     
     
140. HOOFNAGLE JH
     Reactivation of hepatitis B.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. FONTANA RJ
     Side effects of long-term oral antiviral therapy for hepatitis B.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. CHEN CJ , Yang HI, Iloeje UH
     Hepatitis B virus DNA levels and outcomes in chronic hepatitis B.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. FELD JJ , Wong DK, Heathcote EJ
     Endpoints of therapy in chronic hepatitis B.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
144. DEGERTEKIN B , Lok AS
     Indications for therapy in hepatitis B.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. MANI H , Kleiner DE
     Liver biopsy findings in chronic hepatitis B.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. TAYLOR BC , Yuan JM, Shamliyan TA, Shaukat A, et al
     Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. TERRAULT NA
     Benefits and risks of combination therapy for hepatitis B.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
148. DIENSTAG JL
     Benefits and risks of nucleoside analog therapy for hepatitis B.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
149. GHANY MG , Doo EC
     Antiviral resistance and hepatitis B therapy.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
150. ANDERSSON KL , Chung RT
     Monitoring during and after antiviral therapy for hepatitis B.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
151. MCMAHON BJ
     The natural history of chronic hepatitis B virus infection.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. KIM WR
     Epidemiology of hepatitis B in the United States.
     Hepatology. 2009;49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
153. LI D , Zheng L, Jin L, Zhou Y, et al
     CD24 polymorphisms affect risk and progression of chronic hepatitis B virus infection.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
154. HA NB , Ha NB, Garcia RT, Trinh HN, et al
     Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
155. ZEITZ J , Mullhaupt B, Fruehauf H, Rogler G, et al
     Hepatic failure due to hepatitis B reactivation in a patient with ulcerative colitis treated with prednisone.
     Hepatology. 2009.
     PubMed     Text format     Related articles   
     
     
     
156. YEOMAN AD , Westbrook RH, Al-Chalabi T, Carey I, et al
     Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. ALY HH , Qi Y, Atsuzawa K, Usuda N, et al
     Strain-dependent viral dynamics and virus-cell interactions in a novel in vitro system supporting the life cycle of blood-borne hepatitis C virus.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. YANO M , Ikeda M, Abe KI, Kawai Y, et al
     Oxidative stress induces anti-hepatitis C virus status via the activation of extracellular signal-regulated kinase.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
159. LEWIN M , Vilgrain V, Ozenne V, Lemoine M, et al
     Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: A prospective magnetic resonance imaging and histological study.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
160. VANNI E , Abate ML, Gentilcore E, Hickman I, et al
     Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
161. PUOTI C , Guarisco R, Bellis L, Spilabotti L, et al
     Diagnosis, management, and treatment of hepatitis C.
     Hepatology. 2009.
     PubMed     Text format     Related articles   
     
     
     
162. CARRENO V , Bartolome J, Castillo I, Quiroga JA, et al
     Hepatitis C virus replication in patients with occult hepatitis C virus infection.
     Hepatology. 2009;49:2128-2129.
     PubMed     Text format     Related articles   
     
     
     
163. CASANOVAS T
     Treatment of chronic hepatitis C in hemodialysis patients.
     Hepatology. 2009;49:2126.
     PubMed     Text format     Related articles   
     
     
     
164. PURNAK T
     The role of effectively treated chronic hepatitis C infection in the development of type 2 diabetes mellitus.
     Hepatology. 2009.
     PubMed     Text format     Related articles   
     
     
     
165. LUCEY MR , Schaubel DE, Guidinger MK, Tome S, et al
     Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
166. LIU Z , Robida JM, Chinnaswamy S, Yi G, et al
     Mutations in the hepatitis C virus polymerase that increase RNA binding can confer resistance to cyclosporine A.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
167. BERG T , Weich V, Teuber G, Klinker H, et al
     Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
168. GAO B , Duan Z, Xu W, Xiong S, et al
     Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
169. MAILLIARD ME , Capadano ME, Hrnicek MJ, Gilroy RK, et al
     Outcomes of a patient-to-patient outbreak of genotype 3a hepatitis C.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
170. ZHANG X , Liu S, Hu T, Liu S, et al
     Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
171. BRUNETTO MR , Moriconi F, Bonino F, Lau GK, et al
     Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.
     Hepatology. 2009;49:1141-50.
     PubMed     Text format     Related articles    Abstract available
     
     
     
172. CHEVALIEZ S , Bouvier-Alias M, Castera L, Pawlotsky JM, et al
     The Cobas AmpliPrep-Cobas TaqMan real-time polymerase chain reaction assay fails to detect hepatitis C virus RNA in highly viremic genotype 4 clinical samples.
     Hepatology. 2009;49:1397-8.
     PubMed     Text format     Related articles   
     
     
     
173. GHANY MG , Strader DB, Thomas DL, Seeff LB, et al
     Diagnosis, management, and treatment of hepatitis C: an update.
     Hepatology. 2009;49:1335-74.
     PubMed     Text format     Related articles   
     
     
     
174. KAPOOR S
     Emerging new chemokine CXCR3 antagonists and their potential clinical and therapeutic applications.
     Hepatology. 2009;49:1400-1.
     PubMed     Text format     Related articles   
     
     
     
175. SANTODOMINGO-GARZON T , Han J, Le T, Yang Y, et al
     Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice.
     Hepatology. 2009;49:1267-76.
     PubMed     Text format     Related articles    Abstract available
     
     
     
176. ROYCHOWDHURY S , McMullen MR, Pritchard MT, Hise AG, et al
     An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice.
     Hepatology. 2009;49:1326-34.
     PubMed     Text format     Related articles    Abstract available
     
     
     
177. MOUCARI R , Mackiewicz V, Lada O, Ripault MP, et al
     Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients.
     Hepatology. 2009;49:1151-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
178. UTO H , Stuver SO, Hayashi K, Kumagai K, et al
     Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     March 2009
179. SEOK JI , Lee DK, Lee CH, Park MS, et al
     Long-term therapy with clevudine for chronic hepatitis B can be associated with myopathy characterized by depletion of mitochondrial DNA.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
180. DOGRU T , Ercin CN, Tapan S, Polat Z, et al
     Insulin resistance in prediction of esophageal varices.
     Hepatology. 2009.
     PubMed     Text format     Related articles   
     
     
     
181. PERRILLO RP
     Hepatitis B surface antigen quantification as a current-day paradox: Obtaining the gold in the face of diminishing returns.
     Hepatology. 2009;49:1063-1065.
     PubMed     Text format     Related articles   
     
     
     
182. HOFMANN WP , Zeuzem S
     Advanced chronic hepatitis C: How to handle if you cannot halt?
     Hepatology. 2009;49:1385-1387.
     PubMed     Text format     Related articles   
     
     
     
183. VERMA S , Maheshwari A, Thuluvath P
     Liver failure as initial presentation of autoimmune hepatitis: Clinical characteristics, predictors of response to steroid therapy, and outcomes.
     Hepatology. 2009;49:1396-1397.
     PubMed     Text format     Related articles   
     
     
     
184. BELLECAVE P , Gouttenoire J, Gajer M, Brass V, et al
     Hepatitis B and C virus coinfection: A novel model system reveals the absence of direct viral interference.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
185. CHAMULITRAT W , Burhenne J, Rehlen T, Pathil A, et al
     Bile salt-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide as a hepatoprotective agent.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2009
186. DELANG L , Paeshuyse J, Vliegen I, Leyssen P, et al
     Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
187. LABONTE P , Begley S, Guevin C, Asselin MC, et al
     PCSK9 impedes hepatitis C virus infection in vitro and modulates liver CD81 expression.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
188. WANG XX , Song ZZ
     Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis.
     Hepatology. 2009;49:1775.
     PubMed     Text format     Related articles   
     
     
     
189. YANG JC , Teng CF, Wu HC, Tsai HW, et al
     Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis.
     Hepatology. 2009;49:1962-1971.
     PubMed     Text format     Related articles    Abstract available
     
     
     
190. YANG WJ , Chang CJ, Yeh SH, Lin WH, et al
     Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3beta kinase pathways.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
191. TENNEY DJ , Rose RE, Baldick CJ, Pokornowski KA, et al
     Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naive patients is rare through 5 years of therapy.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
192. FLISIAK R , Feinman SV, Jablkowski M, Horban A, et al
     The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naive hepatitis C patients.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
193. BACON BR , Shiffman ML, Mendes F, Ghalib R, et al
     Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
194. LOK AS , Everhart JE, Chung RT, Kim HY, et al
     Evolution of hepatic steatosis in patients with advanced hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
195. SEBASTIANI G , Halfon P, Castera L, Pol S, et al
     SAFE biopsy: A validated method for large-scale staging of liver fibrosis in chronic hepatitis C.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
196. HUANG CF , Dai CY, Huang JF, Chuang WL, et al
     A crossing in therapy for hepatitis C virus genotype 2 or 3: Increasing ribavirin dose with shortened duration or reducing ribavirin dose with standard duration.
     Hepatology. 2009;49:1395-1396.
     PubMed     Text format     Related articles   
     
     
     
197. TAI DI , Lin SM, Sheen IS, Chu CM, et al
     Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
198. DAHARI H , Cotler SJ, Layden TJ, Perelson AS, et al
     Hepatitis B virus clearance rate estimates.
     Hepatology. 2009;49:1779-1780.
     PubMed     Text format     Related articles   
     
     
     
199. MASUZAKI R , Tateishi R, Yoshida H, Goto E, et al
     Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
200. ALLAIN JP , Belkhiri D, Vermeulen M, Crookes R, et al
     Characterization of occult hepatitis B virus strains in south african blood donors.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
201. WELZEL TM , Morgan TR, Bonkovsky HL, Naishadham D, et al
     Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
202. LEMMERS A , Moreno C, Gustot T, Marechal R, et al
     The interleukin-17 pathway is involved in human alcoholic liver disease.
     Hepatology. 2009;49:646-57.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2009
203. AGHEMO A , Grazia Rumi M, Maria Prati G, Colombo M, et al
     The optimal ribavirin dose for patients infected with hepatitis C virus genotype 3: Should we utilize more?
     Hepatology. 2009;49.
     PubMed     Text format     Related articles   
     
     
     
204. HASSAN M , Selimovic D, Ghozlan H, Abdel-Kader O, et al
     Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
205. PARENT R , Qu X, Petit MA, Beretta L, et al
     The heat shock cognate protein 70 is associated with hepatitis C virus particles and modulates virus infectivity.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
206. BRENNDORFER ED , Karthe J, Frelin L, Cebula P, et al
     Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase.
     Hepatology. 2009;49:1810-1820.
     PubMed     Text format     Related articles    Abstract available
     
     
     
207. LONGATO L , de la Monte S, Kuzushita N, Horimoto M, et al
     Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver.
     Hepatology. 2009;49:1935-1943.
     PubMed     Text format     Related articles    Abstract available
     
     
     
208. RIENER MO , Stenner F, Liewen H, Soll C, et al
     Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
209. YOUNOSSI ZM , Baranova A, Afendy A, Collantes R, et al
     Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon-alfa and ribavirin.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
210. DING FX , Wang F, Lu YM, Li K, et al
     Multiepitope peptide-loaded virus-like particles as a vaccine against hepatitis B virus-related hepatocellular carcinoma.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
211. SEO YS , Um SH, Jung ES, Yim HJ, et al
     Serum alanine aminotransferase level alone may not accurately represent necro-inflammation in patients with acute hepatitis.
     Hepatology. 2009;49:1053-1054.
     PubMed     Text format     Related articles   
     
     
     
212. MYERS RP , Shaheen AA
     Hepatitis C, alcohol abuse, and unintentional overdoses are risk factors for acetaminophen-related hepatotoxicity.
     Hepatology. 2009;49:1399-1400.
     PubMed     Text format     Related articles   
     
     
     
213. GRAZIADEI IW , Vogel W
     Treatment of patients infected with chronic hepatitis C genotype 2 and 3: More data, more questions?
     Hepatology. 2009;49:345-347.
     PubMed     Text format     Related articles   
     
     
     
214. MORICE Y , Ratinier M, Miladi A, Chevaliez S, et al
     Seroconversion to hepatitis C virus alternate reading frame protein during acute infection.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
215. CHENG L , You Q, Yin H, Holt M, et al
     Effect of polyI:C cotreatment on halothane-induced liver injury in mice.
     Hepatology. 2009;49:215-26.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
216. KAPOOR S
     Beyond hepatitis C: The anti-inflammatory role of heme oxygenase-1 in systemic infections.
     Hepatology. 2008;49:1052.
     PubMed     Text format     Related articles   
     
     
     
217. MURATA M , Matsuzaki K, Yoshida K, Sekimoto G, et al
     Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
218. MOREAU I , Kenny-Walsh E, Crosbie O, Fanning LJ, et al
     Histological changes in hepatitis C virus antibody-positive, hepatitis C virus RNA-negative subjects suggest persistent virus infection.
     Hepatology. 2008.
     PubMed     Text format     Related articles   
     
     
     
219. MACPARLAND SA , Pham TN, Guy CS, Michalak TI, et al
     Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
220. AMINI-BAVIL-OLYAEE S , Herbers U, Sheldon J, Luedde T, et al
     The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positve and hepatitis B e antigen-negative hepatitis B virus strains.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
221. SAGNELLI E , Coppola N, Pisaturo M, Masiello A, et al
     HBV superinfection in HCV chronic carriers: A disease that is frequently severe but associated with the eradication of HCV.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
222. KAMILI S , Sozzi V, Thompson G, Campbell K, et al
     Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
223. FIEL MI , Schiano T
     Jaundice developing in a patient with hepatitis C 4 months after liver transplantation.
     Hepatology. 2008;49:695-696.
     PubMed     Text format     Related articles   
     
     
     
224. SERRUYS B , Van Houtte F, Verbrugghe P, Leroux-Roels G, et al
     Llama-derived single-domain intrabodies inhibit secretion of hepatitis B virions in mice.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
225. BRINKER AD , Wassel RT, Lyndly J, Serrano J, et al
     Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
226. GAUDIERI S , Rauch A, Pfafferott K, Barnes E, et al
     Hepatitis C virus drug resistance and immune-driven adaptations: Relevance to new antiviral therapy.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
227. HEYDTMANN M , Adams DH
     Chemokines in the immunopathogenesis of hepatitis C infection.
     Hepatology. 2008;49:676-688.
     PubMed     Text format     Related articles    Abstract available
     
     
     
228. MOLLEKEN C , Sitek B, Henkel C, Poschmann G, et al
     Detection of novel biomarkers of liver cirrhosis by proteomic analysis.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2008
229. LEWIN SR , Ribeiro RM, Avihingsanon A, Bowden S, et al
     Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1-hepatitis B virus coinfected individuals: Similar effectiveness of lamivudine, tenofovir, or combination therapy.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
230. TILLMANN H , Patel K, McHutchison J
     Hepatitis B virus viral load and treatment decision.
     Hepatology. 2008;49:699.
     PubMed     Text format     Related articles   
     
     
     
231. MEJIAS M , Garcia-Pras E, Tiani C, Miquel R, et al
     Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
232. WIESNER RH
     Is there disease progression in patients who are hepatitis C virus antibody-positive and hepatitis C virus RNA-seronegative?
     Hepatology. 2008;48:1734-1736.
     PubMed     Text format     Related articles   
     
     
     
233. LUCIDARME D , Foucher J, Le Bail B, Vergniol J, et al
     Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
234. WU J , Meng Z, Jiang M, Pei R, et al
     Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
235. URA S , Honda M, Yamashita T, Ueda T, et al
     Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
236. CALVARUSO V , Burroughs AK, Standish R, Manousou P, et al
     Computer-assisted image analysis of liver collagen: Relationship to ishak scoring and hepatic venous pressure gradient.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
237. CASTANO G , Sookoian S
     Female sex and autoimmune hepatitis and the risk of portopulmonary hypertension.
     Hepatology. 2008;48:2090.
     PubMed     Text format     Related articles   
     
     
     
238. GEORGE SL , Bacon BR, Brunt EM, Mihindukulasuriya KL, et al
     Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
239. NA TY , Shin YK, Roh KJ, Kang SA, et al
     Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
240. DEGERTEKIN B , Lok AS
     Do guidelines preclude hepatitis B patients from receiving treatment?
     Hepatology. 2008;49:700-701.
     PubMed     Text format     Related articles   
     
     
     
241. TREHANPATI N , Geffers R, Hissar S, Riese P, et al
     Gene expression signatures of peripheral CD4+ T cells clearly discriminate between patients with acute and chronic hepatitis B infection.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
242. YE L , Wang X, Wang S, Wang Y, et al
     CD56(+) T cells inhibit hepatitis C virus replication in human hepatocytes.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
243. KNETEMAN NM , Howe AY, Gao T, Lewis J, et al
     HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity In Vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
244. HOU X , Zhou R, Wei H, Sun R, et al
     NKG2D-retinoic acid early inducible-1 recognition between natural killer cells and kupffer cells in a novel murine natural killer cell-dependent fulminant hepatitis.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
245. DAI CY , Chuang WL, Huang JF, Yu ML, et al
     Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL.
     Hepatology. 2008;49:704-705.
     PubMed     Text format     Related articles   
     
     
     
246. CHAN HL
     Revisiting the treatment recommendations for chronic hepatitis B.
     Hepatology. 2008;49:700.
     PubMed     Text format     Related articles   
     
     
     October 2008
247. BERNUAU J , Nicand E, Durand F
     Hepatitis E-associated acute liver failure in pregnancy: An Indian puzzle.
     Hepatology. 2008;48:1380-1382.
     PubMed     Text format     Related articles   
     
     
     
248. TACKE F , Weiskirchen R, Trautwein C
     Liver function critically determines serum retinol-binding protein 4 (RBP4) levels in patients with chronic liver disease and cirrhosis.
     Hepatology. 2008;48:1724-1725.
     PubMed     Text format     Related articles   
     
     
     
249. WELKER MW , Zeuzem S
     Occult hepatitis C: How convincing are the current data?
     Hepatology. 2008.
     PubMed     Text format     Related articles   
     
     
     
250. WASMUTH HE , Tag CG, Van de Leur E, Hellerbrand C, et al
     The marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
251. ARASE Y , Suzuki F, Suzuki Y, Akuta N, et al
     Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
252. 
     Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia.
     Hepatology. 2008;49:658-664.
     PubMed     Text format     Related articles   
     
     
     
253. NAKASHIMA H , Kinoshita M, Nakashima M, Habu Y, et al
     Superoxide produced by Kupffer cells is an essential effector in concanavalin A-induced hepatitis in mice.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
254. SHALEV I , Wong KM, Foerster K, Zhu Y, et al
     The novel CD4(+)CD25(+) regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
255. HAGIST S , Sultmann H, Millonig G, Hebling U, et al
     In vitro-targeted gene identification in patients with hepatitis C using a genome-wide microarray technology.
     Hepatology. 2008;49:378-386.
     PubMed     Text format     Related articles    Abstract available
     
     
     
256. AITKEN CK , Lewis J, Tracy SL, Spelman T, et al
     High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
257. MANGIA A , Minerva N, Bacca D, Cozzolongo R, et al
     Determinants of relapse after a short (12 weeks) course of antiviral therapy and re-treatment efficacy of a prolonged course in patients with chronic hepatitis C virus genotype 2 or 3 infection.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
258. GOTTWEIN JM , Scheel TK, Jensen TB, Lademann JB, et al
     Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
259. BELLECAVE P , Moradpour D
     A fresh look at interferon-alpha signaling and treatment outcomes in chronic hepatitis C.
     Hepatology. 2008;48:1330-3.
     PubMed     Text format     Related articles    Abstract available
     
     
     
260. AGGARWAL R
     Hepatitis E: does it cause chronic hepatitis?
     Hepatology. 2008;48:1328-30.
     PubMed     Text format     Related articles    Abstract available
     
     
     
261. DORE GJ , Haber PS
     Tell me it ain't so: patient-to-patient transmission of hepatitis C in an endoscopy clinic.
     Hepatology. 2008;48:1333-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
262. NGUYEN GC , Sam J, Thuluvath PJ
     Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis.
     Hepatology. 2008;48:1336-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
263. CHEN TH , Chiu SY
     Re: Diabetes mellitus, chronic hepatitis C, and hepatocellular carcinoma.
     Hepatology. 2008;48:1348-9.
     PubMed     Text format     Related articles   
     
     
     
264. POCKROS P , Nelson D, Godofsky E, Rodriguez-Torres M, et al
     High relapse rate seen at week 72 for patients treated with R1626 combination therapy.
     Hepatology. 2008;48:1349-50.
     PubMed     Text format     Related articles   
     
     
     September 2008
265. LEUNG N , Peng CY, Hann HW, Sollano J, et al
     Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
266. CAMMA C , Petta S, Di Marco V, Bronte F, et al
     Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
267. PUGNALE P , Pazienza V, Guilloux K, Negro F, et al
     Hepatitis delta virus inhibits alpha interferon signaling.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
268. BENEDICTO I , Molina-Jimenez F, Barreiro O, Maldonado-Rodriguez A, et al
     Hepatitis C virus envelope components alter localization of hepatocyte tight junction-associated proteins and promote occludin retention in the endoplasmic reticulum.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
269. PALLIER C , Rodriguez C, Brillet R, Nordmann P, et al
     Complex dynamics of hepatitis B virus resistance to adefovir.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
270. ZHONG YD , Yang YF
     Diabetes mellitus, chronic hepatitis C, and hepatocellular carcinoma.
     Hepatology. 2008.
     PubMed     Text format     Related articles   
     
     
     
271. YOON JC , Shiina M, Ahlenstiel G, Rehermann B, et al
     Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
272. LAGUNO M , Cifuentes C, Murillas J, Veloso S, et al
     Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
273. EL-SERAG HB , Engels EA, Landgren O, Chiao E, et al
     Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
274. ASSELAH T , Bieche I, Laurendeau I, Martinot-Peignoux M, et al
     Significant gene expression differences in histologically "Normal" liver biopsies: Implications for control tissue.
     Hepatology. 2008;48:953-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
275. LONARDO A , Loria P
     The hepatitis C virus-associated dysmetabolic syndrome.
     Hepatology. 2008;48:1018-1019.
     PubMed     Text format     Related articles   
     
     
     
276. BOWEN DG
     Of mice and molecular mimicry: Modeling autoimmune hepatitis.
     Hepatology. 2008;48:1013-1015.
     PubMed     Text format     Related articles   
     
     
     
277. XIN YN , Xuan SY
     Spontaneous hepatitis B surface antigen seroclearance confers appreciably high rates except in patients with relapse of hepatitis.
     Hepatology. 2008;48:1021-1022.
     PubMed     Text format     Related articles   
     
     
     
278. YU ML , Dai CY, Huang JF, Chuang WL, et al
     Rapid virological response to peginterferon and ribavirin for hepatitis C genotype 1: The role of weight-based ribavirin exposure.
     Hepatology. 2008;48:1019-1020.
     PubMed     Text format     Related articles   
     
     
     
279. DAHARI H , Shudo E, Ribeiro RM, Perelson AS, et al
     Modeling complex decay profiles of hepatitis B virus during antiviral therapy.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
280. FUJITA T
     Retinol-binding protein 4 as a circulating marker of hepatic steatosis.
     Hepatology. 2008;48:1725.
     PubMed     Text format     Related articles   
     
     
     
281. TANG H , Da L, Mao Y, Li Y, et al
     Hepatitis B virus X protein sensitizes cells to starvation-induced autophagy via up-regulation of beclin 1 expression.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
282. DANDRI M , Murray JM, Lutgehetmann M, Volz T, et al
     Virion half-life in chronic hepatitis B infection is strongly correlated with levels of viremia.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
283. MATTHEWS GV , Avihingsanon A, Lewin SR, Amin J, et al
     A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naive individuals in Thailand.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
284. SIR D , Chen WL, Choi J, Wakita T, et al
     Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
285. MCGOVERN BH , Abu Dayyeh BK, Chung RT
     Avoiding therapeutic pitfalls: The rational use of specifically targeted agents against hepatitis C infection.
     Hepatology. 2008;48:1700-1712.
     PubMed     Text format     Related articles    Abstract available
     
     
     
286. MARHENKE S , Lamle J, Buitrago-Molina LE, Canon JM, et al
     Activation of nuclear factor E2-related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development.
     Hepatology. 2008;48:487-96.
     PubMed     Text format     Related articles    Abstract available
     
     
     
287. DALGARD O , Mangia A
     Short treatment to patients with genotype 2 or 3.
     Hepatology. 2008;48:694.
     PubMed     Text format     Related articles   
     
     
     
288. ARGO CK , Loria P, Caldwell SH, Lonardo A, et al
     Statins in liver disease: a molehill, an iceberg, or neither?
     Hepatology. 2008;48:662-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2008
289. DAI CY , Chuang WL, Huang JF, Hsieh MY, et al
     Rapid virological response in hepatitis C virus genotype 1 and early ribavirin exposure.
     Hepatology. 2008;48:692-693.
     PubMed     Text format     Related articles   
     
     
     
290. IORIO R , Cirillo F, Terlizzi V, Giannattasio A, et al
     Children with chronic hepatitis C: What future?
     Hepatology. 2008;48:691-692.
     PubMed     Text format     Related articles   
     
     
     
291. LAGGING M , Langeland N, Pedersen C, Farkkila M, et al
     Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection.
     Hepatology. 2008;48:695.
     PubMed     Text format     Related articles   
     
     
     
292. GRIFFIN S , Stgelais C, Owsianka AM, Patel AH, et al
     Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
293. BERENGUER M
     Treatment of chronic hepatitis C in hemodialysis patients.
     Hepatology. 2008;48:1690-1699.
     PubMed     Text format     Related articles    Abstract available
     
     
     
294. MARUKIAN S , Jones CT, Andrus L, Evans MJ, et al
     Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
295. MEULEMAN P , Hesselgesser J, Paulson M, Vanwolleghem T, et al
     Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo.
     Hepatology. 2008;48:1761-1768.
     PubMed     Text format     Related articles    Abstract available
     
     
     
296. KUNTZEN T , Timm J, Berical A, Lennon N, et al
     Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naive patients.
     Hepatology. 2008;48:1769-1778.
     PubMed     Text format     Related articles    Abstract available
     
     
     
297. MARTIN-LLUESMA S , Schaeffer C, Robert EI, van Breugel PC, et al
     Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
298. SHIRAKAWA H , Matsumoto A, Joshita S, Komatsu M, et al
     Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
299. ANGUS PW , Patterson SJ, Strasser SI, McCaughan GW, et al
     A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
300. TAN JA , Joseph TA, Saab S
     Treating hepatitis C in the prison population is cost-saving.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
301. ZHU Z , Wilson AT, Mathahs MM, Wen F, et al
     Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury.
     Hepatology. 2008;48:1430-1439.
     PubMed     Text format     Related articles    Abstract available
     
     
     
302. JONES DE , Palmer JM, Burt AD, Kirby JA, et al
     The specificity of liver inflammation in mouse models of primary biliary cirrhosis.
     Hepatology. 2008.
     PubMed     Text format     Related articles   
     
     
     
303. PAPATHEODORIDIS GV , Manesis EK, Manolakopoulos S, Elefsiniotis IS, et al
     Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
304. SU CW , Wu JC, Lee SD
     Is entecavir ideal for the treatment of lamivudine-refractory chronic hepatitis B?
     Hepatology. 2008;48:1726-1727.
     PubMed     Text format     Related articles   
     
     
     
305. XIAO Y , Zhang Y
     Suppressor of cytokine signaling-1, a possible cause for regulatory T cells in hepatitis?
     Hepatology. 2008.
     PubMed     Text format     Related articles   
     
     
     
306. MORISHIMA C , Morgan TR, Everhart JE, Wright EC, et al
     Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis C.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
307. YANG W , Hood BL, Chadwick SL, Liu S, et al
     Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
308. CZAJA AJ
     Performance parameters of the diagnostic scoring systems for autoimmune hepatitis.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
309. ZEREMSKI M , Petrovic LM, Chiriboga L, Brown QB, et al
     Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
310. LA VECCHIA C
     Cancer and liver cancer prevention: is it a fact or just a potential?
     Hepatology. 2008;48:7-9.
     PubMed     Text format     Related articles   
     
     
     
311. BLUHER M , Tonjes A, Stumvoll M
     Does retinol-binding protein 4 cause or reflect fatty liver disease?
     Hepatology. 2008;48:4-6.
     PubMed     Text format     Related articles   
     
     
     
312. KAWUT SM , Krowka MJ, Trotter JF, Roberts KE, et al
     Clinical risk factors for portopulmonary hypertension.
     Hepatology. 2008;48:196-203.
     PubMed     Text format     Related articles    Abstract available
     
     
     
313. SEKI E , Brenner DA
     Toll-like receptors and adaptor molecules in liver disease: update.
     Hepatology. 2008;48:322-35.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2008
314. MIURA K , Taura K, Kodama Y, Schnabl B, et al
     Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
315. TONG MJ , Hsien C, Hsu L, Sun HE, et al
     Treatment recommendations for chronic hepatitis B: An evaluation of current guidelines based on a natural history study in the United States.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
316. VON WAGNER M , Hofmann WP, Teuber G, Berg T, et al
     Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infection.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
317. HOARE M , Gelson WT, Rushbrook SM, Curran MD, et al
     Histological changes in HCV antibody-positive, HCV RNA-negative subjects suggest persistent virus infection.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
318. FRIED MW , Jensen DM, Rodriguez-Torres M, Nyberg LM, et al
     Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: Randomized study of higher doses of peginterferon alpha-2a and ribavirin.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2008
319. BALAN V , Ruppert K, Demetris AJ, Ledneva T, et al
     Long-term outcome of human leukocyte antigen mismatching in liver transplantation: Results of the national institute of diabetes and digestive and kidney diseases liver transplantation database.
     Hepatology. 2008;48:878-888.
     PubMed     Text format     Related articles    Abstract available
     
     
     
320. KATO T , Choi Y, Elmowalid G, Sapp RK, et al
     Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
321. YEOMAN AD , Al-Chalabi T, Karani JB, Quaglia A, et al
     Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening.
     Hepatology. 2008;48:863-870.
     PubMed     Text format     Related articles    Abstract available
     
     
     
322. EVANS A , Riva A, Cooksley H, Phillips S, et al
     Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
323. MARCELLIN P , Chang TT, Lim SG, Sievert W, et al
     Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.
     Hepatology. 2008;48:750-758.
     PubMed     Text format     Related articles    Abstract available
     
     
     
324. MUHANNA N , Doron S, Wald O, Horani A, et al
     Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis.
     Hepatology. 2008;48:963-977.
     PubMed     Text format     Related articles    Abstract available
     
     
     
325. ZEUZEM S , Yoshida EM, Benhamou Y, Pianko S, et al
     Albinterferon alfa-2b dosed every two or four weeks in interferon-naive patients with genotype 1 chronic hepatitis C.
     Hepatology. 2008;48:407-417.
     PubMed     Text format     Related articles    Abstract available
     
     
     
326. CUA IH , Hui JM, Kench JG, George J, et al
     Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
327. BELDI G , Wu Y, Banz Y, Nowak M, et al
     Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.
     Hepatology. 2008;48:841-852.
     PubMed     Text format     Related articles    Abstract available
     
     
     April 2008
328. PALMER C , Hampartzoumian T, Lloyd A, Zekry A, et al
     A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection.
     Hepatology. 2008;48:374-384.
     PubMed     Text format     Related articles    Abstract available
     
     
     
329. O'BRIEN C , Joshi S, Feld JJ, Guindi M, et al
     Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis.
     Hepatology. 2008;48:550-556.
     PubMed     Text format     Related articles    Abstract available
     
     
     
330. NEVEU B , Debeaupuis E, Echasserieau K, le Moullac-Vaidye B, et al
     Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
331. KARTHE J , Tessmann K, Li J, Machida R, et al
     Specific targeting of hepatitis C virus core protein by an intracellular single-chain antibody of human origin.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
332. WOUTERS K , van Gorp PJ, Bieghs V, Gijbels MJ, et al
     Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis.
     Hepatology. 2008;48:474-486.
     PubMed     Text format     Related articles    Abstract available
     
     
     
333. VAN DER POORTEN D , Milner KL, Hui J, Hodge A, et al
     Visceral fat: A key mediator of steatohepatitis in metabolic liver disease.
     Hepatology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     March 2008
334. SASAKI M , Ikeda H, Yamaguchi J, Nakada S, et al
     Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence.
     Hepatology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: